Stock Information
Disc Medicine Inc (IRON)
Ticker Symbol: IRON
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $2,460.56 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -5.9802
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -32.8%
Latest News
-
Replimune Group shares are trading lower after HC Wainwright downgraded the stock from Buy to Sell.
Mon, Apr 13, 2026 7:47 AM
-
Reuters Cites Statement From Roche Saying To Date About 760 Ambulatory DMD Patients Have Been Treated With Elevidys; To Date There Have Been No Treatment-Related Fatalities In Ambulatory DMD Patients; Actively Working With Physicians And Patient Organizations To Address Their Questions On Elevidys
Tue, Jul 29, 2025 10:35 AM
-
Disc Medicine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
Tue, May 5, 2026 11:21 AM
-
Disc Medicine Q1 EPS $(1.65) Beats $(1.73) Estimate
Tue, May 5, 2026 8:37 AM
-
Disc Medicine Reports First Quarter 2026 Financial Results and Provides Business Update
Tue, May 5, 2026 8:30 AM
Key Financials
Financial data not available
